Organic cation transporters

被引:214
作者
Koepsell, H. [1 ]
Schmitt, B. M. [1 ]
Gorboulev, V. [1 ]
机构
[1] Univ Wurzburg, Inst Anat & Zellbiol, D-97070 Wurzburg, Germany
来源
REVIEWS OF PHYSIOLOGY, BIOCHEMISTRY AND PHARMACOLOGY, VOL 150 | 2004年 / 150卷
关键词
D O I
10.1007/s10254-003-0017-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Over the last 15 years, a number of transporters that translocate organic cations were characterized functionally and also identified on the molecular level. Organic cations include endogenous compounds such as monoamine neurotransmitters, choline, and coenzymes, but also numerous drugs and xenobiotics. Some of the cloned organic cation transporters accept one main substrate or structurally similar compounds (oligospecific transporters), while others translocate a variety of structurally diverse organic cations (polyspecific transporters). This review provides a survey of cloned organic cation transporters and tentative models that illustrate how different types of organic cation transporters, expressed at specific subcellular sites in hepatocytes and renal proximal tubular cells, are assembled into an integrated functional framework. We briefly describe oligospecific Na+- and Cl--dependent monoamine neurotransmitter transporters (SLC6-family), high-affinity choline transporters (SLC5-family), and high-affinity thiamine transporters (SLC19-family), as well as polyspecific transporters that translocate some organic cations next to their preferred, noncationic substrates. The polyspecific cation transporters of the SLC22 family including the subtypes OCT1-3 and OCTN1-2 are presented in detail, covering the current knowledge about distribution, substrate specificity, and recent data on their electrical properties and regulation. Moreover, we discuss artificial and spontaneous mutations of transporters of the SLC22 family that provide novel insight as to the function of specific protein domains. Finally, we discuss the clinical potential of the increasing knowledge about polymorphisms and mutations in polyspecific organic cation transporters.
引用
收藏
页码:36 / 90
页数:55
相关论文
共 315 条
[1]   REGULATION OF PLASMA CHOLINE BY RENAL TUBULE - BIDIRECTIONAL TRANSPORT OF CHOLINE [J].
ACARA, M ;
RENNICK, B .
AMERICAN JOURNAL OF PHYSIOLOGY, 1973, 225 (05) :1123-1128
[2]  
AKAIKE N, 1984, J PHARMACOL EXP THER, V228, P225
[3]   PARTIAL-PURIFICATION AND RECONSTITUTION OF THE HUMAN MULTIDRUG-RESISTANCE PUMP - CHARACTERIZATION OF THE DRUG-STIMULATABLE ATP HYDROLYSIS [J].
AMBUDKAR, SV ;
LELONG, IH ;
ZHANG, JP ;
CARDARELLI, CO ;
GOTTESMAN, MM ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (18) :8472-8476
[4]   Molecular cloning of a human, hemicholinium-3-sensitive choline transporter [J].
Apparsundaram, S ;
Ferguson, SM ;
George, AL ;
Blakely, RD .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 276 (03) :862-867
[5]   Molecular cloning and characterization of a murine hemicholinium-3-sensitive choline transporter [J].
Apparsundaram, S ;
Ferguson, SM ;
Blakely, RD .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2001, 29 :711-716
[6]   Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1 [J].
Arndt, P ;
Volk, C ;
Gorboulev, V ;
Budiman, T ;
Popp, C ;
Ulzheimer-Teuber, I ;
Akhoundova, A ;
Koppatz, S ;
Bamberg, E ;
Nagel, G ;
Koepsell, H .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2001, 281 (03) :F454-F468
[7]   Genomic structure and in vivo expression of the human organic anion transporter 1 (hOAT1) gene [J].
Bahn, A ;
Prawitt, D ;
Buttler, D ;
Reid, G ;
Enklaar, T ;
Wolff, NA ;
Ebbinghaus, C ;
Hillemann, A ;
Schulten, HJ ;
Gunawan, B ;
Füzesi, L ;
Zabel, B ;
Burckhardt, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 275 (02) :623-630
[8]   The human organic cation transporter (hOCT2) recognizes the degree of substrate ionization [J].
Barendt, WM ;
Wright, SH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (25) :22491-22496
[9]   Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ("ecstasy") in serotonin transporter-deficient mice [J].
Bengel, D ;
Murphy, DL ;
Andrews, AM ;
Wichems, CH ;
Feltner, D ;
Heils, A ;
Mössner, R ;
Westphal, H ;
Lesch, KP .
MOLECULAR PHARMACOLOGY, 1998, 53 (04) :649-655
[10]   Characterization of L-carnitine transport into rat skeletal muscle plasma membrane vesicles [J].
Berardi, S ;
Stieger, B ;
Hagenbuch, B ;
Carafoli, E ;
Krähenbühl, S .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (07) :1985-1994